BioXcel Therapeutics Inc (BTAI) Insider Trading
- $260,881.51
- $23,762,477.54
- April 4, 2024
- Vimal Mehta
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
April 4, 2024 | CFO | 1,069 | $2.63 | Sell | $2,811.47 | |
April 4, 2024 | CEO | 5,268 | $2.62 | Sell | $13,802.16 | |
April 4, 2024 | Insider | 165 | $2.62 | Sell | $432.30 | |
June 15, 2023 | CEO | 30,000 | $21.54 | Sell | $646,200.00 | |
May 22, 2023 | CEO | 6,500 | $25.79 | Sell | $167,635.00 | |
May 15, 2023 | Insider | 1,785 | $27.32 | Sell | $48,766.20 | |
May 15, 2023 | CFO | 5,000 | $27.17 | Sell | $135,850.00 | |
April 6, 2023 | Director | 60,000 | $17.32 | Sell | $1,039,200.00 | |
March 20, 2023 | CEO | 34,500 | $18.32 | Sell | $632,040.00 | |
March 15, 2023 | CFO | 2,084 | $19.50 | Sell | $40,638.00 | |
March 15, 2023 | Insider | 985 | $19.69 | Sell | $19,394.65 | |
Jan. 20, 2023 | Insider | 50,000 | $30.00 | Sell | $1,500,000.00 | |
Jan. 5, 2023 | Director | 25,889 | $22.34 | Sell | $578,360.26 | |
Dec. 16, 2022 | CEO | 30,000 | $19.44 | Sell | $583,200.00 | |
Nov. 10, 2022 | Director | 27,450 | $15.00 | Sell | $411,750.00 | |
June 25, 2021 | CEO | 473,250 | $30.83 | Sell | $14,590,297.50 | |
Feb. 17, 2021 | Insider | 25,000 | $55.58 | Sell | $1,389,500.00 | |
Jan. 25, 2021 | Insider | 15,000 | $48.39 | Sell | $725,850.00 | |
Jan. 19, 2021 | Insider | 25,000 | $49.47 | Sell | $1,236,750.00 | |
Aug. 22, 2019 | Director | 8,446 | $8.74 | Buy | $73,818.04 | |
Aug. 15, 2019 | CEO | 2,983 | $8.64 | Buy | $25,773.12 | |
Aug. 13, 2019 | CEO | 1,000 | $8.75 | Buy | $8,750.00 | |
Aug. 13, 2019 | Insider | 6,547 | $8.67 | Buy | $56,762.49 | |
Dec. 14, 2018 | CEO | 2,000 | $4.38 | Buy | $8,760.00 | |
Dec. 7, 2018 | Director | 8,795 | $5.01 | Buy | $44,062.95 | |
Dec. 4, 2018 | Insider | 900 | $5.21 | Buy | $4,689.00 | |
Dec. 4, 2018 | Director | 4,007 | $5.13 | Buy | $20,555.91 | |
Dec. 3, 2018 | CEO | 1,000 | $5.17 | Buy | $5,170.00 | |
Dec. 3, 2018 | CFO | 500 | $5.20 | Buy | $2,600.00 | |
Nov. 30, 2018 | CEO | 1,000 | $5.10 | Buy | $5,100.00 | |
Nov. 30, 2018 | Insider | 450 | $5.20 | Buy | $2,340.00 | |
Nov. 29, 2018 | CFO | 500 | $5.00 | Buy | $2,500.00 |
Insiders are both buying and selling BioXcel Therapeutics Inc stock.
The insider traders at BioXcel Therapeutics Inc are: Vimal Mehta, Frank Yocca, Richard I Steinhart, Peter Mueller, Krishnan Nandabalan, Vincent O'neill, and Javier Rodriguez
The most active insider trader at BioXcel Therapeutics Inc is Vimal Mehta with 11 trades.
Vimal Mehta has sold the most BioXcel Therapeutics Inc stock with a total value of $16,646,976.82.
Peter Mueller has bought the most BioXcel Therapeutics Inc stock with a total value of $212,254.94.
The most recent insider trade for BioXcel Therapeutics Inc was on April 4, 2024.
The single biggest insider buy for BioXcel Therapeutics Inc was from Peter Mueller with a total value of $73,818.04 on Aug. 22, 2019.
The single biggest insider sell for BioXcel Therapeutics Inc was from Vimal Mehta with a total value of $14,590,297.50 on June 25, 2021.